X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Detecting Traces of β-Lactam Antibiotics Using UHPLC-MS-MS

Content Team by Content Team
24th November 2022
in News, Research & Development

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The identification and detection of the β-lactams cephapirin and ceftiofur in cleaning solutions of the production reactors have been validated using ultra-performance liquid chromatography with a triple quadrupole mass spectrometry, or UHPLC-MS/MS, according to a paper published in the journal Molecules.

It is important and regulated to conduct trace detection of β-lactam antibiotics in cleaning rinse solutions and production aids in pharmaceutical plants. Patients who utilise medications have a high risk of experiencing cross contamination with β-lactams because even minute levels of them might result in potentially fatal responses. Additionally, during the cleaning procedure, pollutants like cephapirin and ceftiofur that are prevalent in production reactors may transfer into the cleaning solution.

According to the research, a number of complex and time-consuming analytical methods have historically been used to determine β-lactams, comprising radioimmunoassay, microbial inhibition, enzyme-linked immunosorbent assay, bioluminescent immunoassay, and biosensors. Hazardous antibiotic pollutants have been identified and removed using molecularly imprinted polymer nanoparticles, as well as other metal and metal oxide nanoparticles. However, according to the article, they lack specificity and are only appropriate when qualitative data is needed.

Another option is to use spectroscopic techniques, but as β-lactam antibiotics lack chromophores, the technique requires a sufficient derivatization to provide colour. The study continued that several spectroscopic approaches suffer from a long analysis time and were created using traditional high-performance liquid chromatography (HPLC) with UV detection. However, LC-MS/MS approaches have not been particularly mentioned for β-lactam derivatives of cephapirin and ceftiofur at trace quantities in medicinal products or on industrial surfaces.

The study said that it is necessary to design an easy, quick, and precise multi-residue analytical approach that involves ultra-high efficiency liquid chromatographic methodology.

Rapid analysis with UHPLC-MS/MS

At an oven temperature of roughly 40 °C, analysis was conducted using a C18 column that was 100mm long, 4.6mm in diameter, and had a 3.5 m particle size. 0.15% formic acid in water and mobile phases A and B of acetonitrile made up the mobile phase. A flow rate of 0.6 mL/min was used.

According to Chittireddy et al research, the lowest limit of discovery for quantitative accuracy and precision was 0.15 parts per billion (ppb), while the lowest limit of quantification was 0.4 ppb. It was fit-for-purpose for detecting and quantifying trace levels of β-lactam contamination, tracking cross – infection in facility surface cleaning, and calculating the adequate standard of limits for regulatory purposes to use a quick and accurate procedure.

Previous Post

Leprosy-Causing Bacteria May Be Able To Regenerate Livers

Next Post

EMA Forms Quality Control Group To Boost Drug Innovation

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

EMA Forms Quality Control Group To Boost Drug Innovation

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In